Znanstveni rad - Izvorni znanstveni rad
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol
BMJ Open, 11 (2021), 3; e044483. https://doi.org/10.1136/bmjopen-2020-044483

Spierings, Julia; van Rhenen, Anna; Welsing, Paco MW; Marijnissen, Anne CA; De Langhe, Ellen; Del Papa, Nicoletta; Dierickx, Daan; Gheorghe, Karina R; Henes, Joerg; Hesselstrand, Roger; Kerre, Tessa; Ljungman, Per; van de Loosdrecht, Arjan A; Marijt, Erik WAF; Mayer, Miro; Schmalzing, Marc; Schroers, Roland; Smith, Vanessa; Voll, Reinhard E; Vonk, Madelon C; Voskuyl, Alexandre E; de Vries-Bouwstra, Jeska K; Walker, Ulrich A; Wuttge, Dirk M; van Laar, Jacob M Više autora...

Citirajte ovaj rad

Spierings, J., van Rhenen, A., Welsing, P. M., Marijnissen, A. C., De Langhe, E., Del Papa, N. ... van Laar, J. M. (2021). A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol. BMJ Open, 11. (3). doi: 10.1136/bmjopen-2020-044483

Spierings, Julia, et al. "A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol." BMJ Open, vol. 11, br. 3, 2021. https://doi.org/10.1136/bmjopen-2020-044483

Spierings, Julia, Anna van Rhenen, Paco MW Welsing, Anne CA Marijnissen, Ellen De Langhe, Nicoletta Del Papa, Daan Dierickx, et al. "A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol." BMJ Open 11, br. 3 (2021). https://doi.org/10.1136/bmjopen-2020-044483

Spierings, J., et al. (2021) 'A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol', BMJ Open, 11(3). doi: 10.1136/bmjopen-2020-044483

Spierings J, van Rhenen A, Welsing PM, Marijnissen AC, De Langhe E, Del Papa N, i sur.. A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol. BMJ Open [Internet]. 18.03.2021. [pristupljeno 23.05.2022.];11(3). doi: 10.1136/bmjopen-2020-044483

J. Spierings, et al., "A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol", BMJ Open, vol. 11, br. 3, Ožujak 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:008893. [Citirano: 23.05.2022.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.